A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C

Completed · Phase 4

Conditions studied: Hepatitis C, Chronic

In brief

This multicenter study will evaluate the correlation of interleukin 28B (IL28B) genotypes with disease characteristics and demographics in treatment-naïve and treatment-experienced chronic hepatitis C patients, including patients with HIV co-infection. There will be a single study visit for testing.

Key facts

Study ID

NCT01675427

Run by

Hoffmann-La Roche

People needed

4766

Starts

2011-08-01

Expected to finish

2013-10-01

Last updated by the study team

2015-08-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult (according to local legislation) male or female patient
• Chronic hepatitis C (CHC)
• Patients naïve to CHC treatment or patients who received prior interferon-based therapy for CHC for whom data on treatment received and treatment outcome is available; information on fibrosis stage prior to previous treatment is also required

You may not qualify if…

• Co-infection with hepatitis B
• History or evidence of decompensated liver disease
• History of major organ transplantation with an existing functional graft (including liver transplantation)
• End stage renal disease

Where it is running

• Study site — Buenos Aires, Argentina
• Study site — Mar del Plata, Argentina
• Study site — Antwerp, Belgium
• Study site — Bruges, Belgium
• Study site — Brussels, Belgium
• Study site — Brussels, Belgium
• Study site — Brussels, Belgium
• Study site — Brussels, Belgium
• Study site — Brussels, Belgium
• Study site — Brussels, Belgium
• Study site — Edegem, Belgium
• Study site — Genk, Belgium
• Study site — Ghent, Belgium
• Study site — Hasselt, Belgium
• Study site — Heusy, Belgium
• Study site — Kortrijk, Belgium
• Study site — Leuven, Belgium
• Study site — Liège, Belgium
• Study site — Ostend, Belgium
• Study site — Roeselare, Belgium
• Study site — Santiago, Chile
• Study site — Santiago, Chile
• Study site — Cairo, Egypt
• Study site — Cairo, Egypt
• Study site — Alexandria, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.